Approval · Notice of Compliance 11353 · 2010
PRINIVIL: Notice of Compliance 11353
Issued April 27, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11353
- Date
- April 27, 2010
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revisions to the Product Monograph: use in hypertensive pediatric patients
- Therapeutic class
- Angiotensin converting enzyme inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PRINIVIL | Not yet assigned | — |
Medicinal ingredients
- LISINOPRIL 5 MG per TAB
- LISINOPRIL 10 MG per TAB
- LISINOPRIL 20 MG per TAB